|
[Related PubMed/MEDLINE] Total Number of Papers: 22
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2021 |
Corneal topographic changes after blepharoptosis surgery in patients with deepening of the upper eyelid sulcus. |
AveK, BCVA, CCT, CYL, HOAs, MRD-1 |
2 |
2021 |
Omidenepag, a Selective, Prostanoid EP2 Agonist, Does Not Suppress Adipogenesis in 3D Organoids of Human Orbital Fibroblasts. |
BIM-A, COL1, FN, HOFs, OMD |
3 |
2021 |
Periocular Adverse Reactions to Omidenepag Isopropyl. |
OMDI |
4 |
2021 |
Prostaglandin F2alpha agonists induced enhancement in collagen1 expression is involved in the pathogenesis of the deepening of upper eyelid sulcus. |
COL1, ECM, HOFs, MMPs, PGF2alpha-ags, TIMPs |
5 |
2021 |
Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis. |
IOP |
6 |
2020 |
Association of Deepening of the Upper Eyelid Sulcus with the Incidence of Blepharoptosis after Glaucoma Filtration Surgery. |
--- |
7 |
2020 |
Changes in Prostaglandin-associated Periorbital Syndrome After Switch from Conventional Prostaglandin F2alpha Treatment to Omidenepag Isopropyl in 11 Consecutive Patients. |
--- |
8 |
2020 |
Effectiveness of Blepharoptosis Surgery in Patients With Deepening of the Upper Eyelid Sulcus. |
--- |
9 |
2020 |
Omidenepag, a non-prostanoid EP2 receptor agonist, induces enlargement of the 3D organoid of 3T3-L1 cells. |
ECM, OMD |
10 |
2020 |
One-Year Follow-Up Study of Changes in Prostaglandin-Associated Periorbital Syndrome After Switch From Conventional Prostaglandin F2alfa to Omidenepag Isopropyl. |
PAPS, PGF2 alpha |
11 |
2020 |
Prostaglandin F2alpha agonist-induced suppression of 3T3-L1 cell adipogenesis affects spatial formation of extra-cellular matrix. |
BIM-A, ECM, PG |
12 |
2020 |
Prostaglandin F2alpha Agonists Negatively Modulate the Size of 3D Organoids from Primary Human Orbital Fibroblasts. |
ECM, HOFs, PG |
13 |
2017 |
Effects of pre-surgical administration of prostaglandin analogs on the outcome of trabeculectomy. |
IOP, PG, POAG |
14 |
2015 |
Prostaglandin-associated periorbitopathy in latanoprost users. |
PAP |
15 |
2014 |
Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy. |
BIM, BIM-A, LAT-A, PG, TAF-A, TRA-A, UNO |
16 |
2014 |
Cross-sectional study of the association between a deepening of the upper eyelid sulcus-like appearance and wide-open eyes. |
UES |
17 |
2014 |
Incidence of deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy with a latanoprost ophthalmic solution. |
IOP, PAP |
18 |
2014 |
Incidence of deepening of the upper eyelid sulcus on treatment with a tafluprost ophthalmic solution. |
BAK, IOP, MD, Taf |
19 |
2013 |
Incidence of deepening of upper eyelid sulcus after topical use of tafluprost ophthalmic solution in Japanese patients. |
--- |
20 |
2012 |
Incidence of deepening of the upper eyelid sulcus after topical use of travoprost ophthalmic solution in Japanese. |
IOP |
21 |
2012 |
Recovery from deepening of the upper eyelid sulcus after switching from bimatoprost to latanoprost. |
BIM, IOP, LAT, PAP |
22 |
2011 |
Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost. |
IOP |
|